SENEXON-S is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is Docusate Sodium; Sennosides A And B.
| Product ID | 68788-9407_fd679f36-fc8c-4115-afbb-7edbb30c3ae7 |
| NDC | 68788-9407 |
| Product Type | Human Otc Drug |
| Proprietary Name | SENEXON-S |
| Generic Name | Docusate Sodium -sennosides |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-05-21 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | Preferred Pharmaceuticals, Inc. |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES A AND B |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2014-05-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2014-05-21 |
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/1 |
| SPL SET ID: | 53048b99-bb1a-4821-94e2-b7999d5617b8 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0536-1247 | Senexon-S | Docusate Sodium 50mg and Sennosides 8.6mg |
| 0536-4086 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
| 0615-7773 | SENEXON-S | docusate sodium-sennosides tablet |
| 0615-8083 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
| 0615-8331 | Senexon-S | Docusate Sodium 50mg and Sennosides 8.6mg |
| 33261-749 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
| 52959-675 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
| 68788-9407 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
| 43063-818 | Docusate Sodium with Sennosides | DOCUSATE SODIUM -SENNOSIDES |